Lancet Commission: Stem cells and regenerative medicineGiulio Cossu, James Wilson, Martin Birchall et al.|The Lancet|2017Cited by 276
Cell Therapy Industry: Billion Dollar Global Business with Unlimited PotentialChris Mason, Natasha L. Davie, David Brindley et al.|Regenerative Medicine|2011Cited by 144
Peak Serum: Implications of Serum Supply for Cell Therapy ManufacturingDavid Brindley, Jon A. Rowley, Natasha L. Davie et al.|Regenerative Medicine|2011Cited by 144
A Decade of Cell Therapy Clinical Trials (2000–2010)Emily J Culme-Seymour, Chris Mason, Natasha L. Davie et al.|Regenerative Medicine|2012Cited by 66
The Impact of Market Volatility on the Cell Therapy IndustryDavid Brindley, Chris Mason, Brock Reeve et al.|Cell stem cell|2011Cited by 30